Research Explorer

Your browser does not support JavaScript or JavaScript is not enabled. Without JavaScript some functions of this webapplication may be disabled or cause error messages. To enable JavaScript, please consult the manual of your browser or contact your system administrator.

Researcher

Mathieu Spaas

5 Results

2022

Impact of radiotherapy parameters on the risk of lymphopenia in urological tumors : a systematic review of the literature

Willeke DanckaertMathieu SpaasKatrien VandecasteeleCarlos De WagterPiet Ost

A1 Journal Article in RADIOTHERAPY AND ONCOLOGY

2021

Checkpoint inhibition in combination with an immunoboost of external beam radiotherapy in solid tumors (CHEERS) : study protocol for a phase 2, open-label, randomized controlled trial

Mathieu SpaasNora SundahlEva HulstaertVibeke KruseSylvie RotteyDaan De MaeseneerVeerle SurmontAnnabel MeiresonLieve BrochezDries Reynders et al.

A1 Journal Article in BMC CANCER

Clinical relevance of serum Kyn/Trp ratio and basal and IFN gamma-upregulated IDO1 expression in peripheral monocytes in early stage melanoma

Annabel MeiresonLiesbeth FerdinandeMarc HaspeslaghBenjamin HennartDelphine AllorgePiet OstNora SundahlMathieu SpaasAnnelies DemeyerLieve Brochez

A1 Journal Article in FRONTIERS IN IMMUNOLOGY

Immune monitoring in melanoma and urothelial cancer patients treated with anti-PD-1 immunotherapy and SBRT discloses tumor specific immune signatures

Annabel MeiresonSimon TavernierSofie Van GassenNora SundahlAnnelies DemeyerMathieu SpaasVibeke KruseLiesbeth FerdinandeJo Van DorpeBenjamin Hennart et al.

A1 Journal Article in CANCERS

Immuno-radiotherapy in solid tumors : preliminary results of the randomized phase 2 CHEERS trial

Mathieu SpaasNora SundahlSylvie RotteyVIBEKE KRUSEDaan De MaeseneerFréderic DuprezPiet DirixVeerle SurmontYolande LievensRobin Van den Begin et al.